Dr. Michael Koelle's lab at Yale University focuses on understanding how brain circuits work by studying the egg-laying behavior in the tiny roundworm C. elegans. The lab aims to pinpoint how various signaling molecules like neurotransmitters and neuropeptides contribute to the activity of these circuits, which can provide insights into human brain diseases. By using advanced techniques such as imaging and genetics, the lab investigates the interactions of different neurons and how they govern behavior.

Dr. Thomas P. Maniatis's lab studies how specific genes help form the connections between neurons in the brain during development. They focus on a group of genes known as protocadherins, which give neurons unique identities necessary for building proper neural circuits. By investigating how mutations in these genes can affect brain wiring, the research aims to understand their role in neurodevelopmental disorders such as autism and schizophrenia. Overall, the lab seeks to uncover the underlying mechanisms that could lead to new treatments for these conditions.

Dr. Subhra Mohapatra's lab at the University of South Florida focuses on understanding the long-term neurological effects of COVID-19, particularly how the virus impacts tau proteins related to neurodegenerative diseases like Alzheimer's. The lab uses mouse models to investigate how aging and COVID-19 infection can lead to neurological issues, aiming to find new ways to prevent or treat these conditions. Through their research, they hope to identify specific molecular targets that can be manipulated to reduce the negative effects of COVID-19 on the brain.

Dr. Jiou Wang's lab at Johns Hopkins University focuses on understanding the underlying causes of neurodegenerative diseases like ALS and frontotemporal dementia (FTD). They investigate how genetic factors, particularly a mutation in the C9orf72 gene, lead to neuronal damage. The lab employs a combination of biochemical, molecular, and genetic techniques to explore how these mutations disrupt protein and RNA functions, contributing to neurodegeneration. Ultimately, their goal is to find new avenues for treatment and intervention for these serious neurological conditions.

Dr. Eric Morrow's lab at Brown University investigates the biological mechanisms behind neurodevelopmental and neurodegenerative disorders. The research focuses on genetic factors, particularly copy number variations (CNVs), that increase the risk of conditions like autism. By studying animal models and human stem cells, the lab seeks to understand how these genetic changes affect brain development and neuronal health, with the goal of developing new therapeutic strategies.

Dr. Chen Gu's lab at Ohio State University focuses on understanding how certain ion channels influence both the immune response and neuron function in the central nervous system (CNS). By studying the interactions between T cells and neurons, particularly in conditions like multiple sclerosis, the lab aims to identify new strategies for neuroprotection and repair that could help address inflammatory demyelinating disorders. They employ a variety of advanced techniques to delve into these complex biological processes.

The lab led by Dr. Jefferson Matthew Taliaferro focuses on understanding how RNA localization impacts neuron function and its misregulation in diseases like ALS. By investigating the RNA-binding protein TDP-43, which is crucial for transporting RNA within neurons, the lab aims to uncover the consequences of RNA mislocalization in neurological disorders. The research combines advanced techniques in live cell imaging and stem cell biology to explore fundamental cellular processes that have implications for developing new therapeutic strategies.

Dr. Konstantin Ichtchenko's lab focuses on developing new treatments for botulinum neurotoxin poisoning, a serious condition that can cause paralysis and respiratory failure. The team aims to create innovative therapeutics that can specifically target and neutralize the neurotoxin's harmful effects within nerve cells. Their work is not only relevant for addressing botulism but also has implications for treating other neurodegenerative diseases.

Dr. Marta Rodriguez Garcia's lab focuses on understanding how aging affects the immune response in the female genital tract (FGT), specifically through the role of neutrophils in preventing infections. The research aims to uncover the mechanisms by which neutrophils provide protection against sexually transmitted infections and how these mechanisms change in older women. By employing advanced techniques like single-cell sequencing and tissue spatial transcriptomics, the lab seeks to develop new strategies for enhancing mucosal immunity in aging populations.

Dr. Yilin Hu's lab at UC Irvine focuses on studying nitrogenase, an important enzyme that converts atmospheric nitrogen into ammonia, which is crucial for agriculture and the environment. The team investigates how nitrogenase operates at a molecular level and seeks to improve its expression in bacteria. Their work aims to find innovative applications for nitrogenase that could enhance crop yields and reduce pollution, ultimately contributing to sustainable agricultural practices.

Dr. Gabriela K. Popescu's research lab focuses on understanding how NMDA receptors function in the brain. These receptors play a crucial role in controlling communication between nerve cells, which is vital for learning and memory. By delving into the molecular details of how these receptors activate, the lab aims to discover new treatments for diseases like Alzheimer's and Parkinson's, particularly for patients with specific genetic variants.

Dr. Yohei Kirino's lab at Thomas Jefferson University focuses on understanding the role of small non-coding RNAs in acute lung injury (ALI), a serious respiratory condition. The lab aims to uncover how specific types of RNA derived from tRNA and rRNA contribute to the inflammatory response in ALI, which is associated with high morbidity and mortality. Using a novel sequencing technique, the lab's research may lead to new insights into potential biomarkers and therapeutic targets for treating this condition.

Dr. Jia Fan's lab focuses on improving the detection and treatment of nontuberculous mycobacterial (NTM) infections using advanced protein analysis techniques. With a particular emphasis on mass spectrometry and computational algorithms, the lab aims to enhance the accuracy of diagnosing specific NTM species and determining their drug resistance. This research is particularly important given the rising incidence of these infections and the need for effective, tailored treatments.

Dr. Thomas James Smith's lab at the University of Texas Medical Branch Galveston focuses on understanding how noroviruses evade the immune system. They investigate the structural dynamics of norovirus capsids, which can change shape to avoid recognition by antibodies. By studying the mouse norovirus model, the lab aims to provide insights that could lead to effective vaccines and treatments for norovirus infections, which cause significant illness worldwide, especially in young children and older adults.

Dr. Issam Ben-Sahra's lab at Northwestern University focuses on understanding how cells grow and develop by studying the complex interactions between nutrient signaling and nucleotide metabolism. They investigate the molecular mechanisms that link signaling pathways to nucleotide production, which are critical for various cell functions like growth and energy production. Their recent work has reshaped our understanding of how nucleotides influence cellular metabolism and has implications for developing new therapeutic strategies.

Dr. Heather Christofk's research lab at UCLA focuses on understanding how nutrients, particularly the amino acid asparagine, regulate cancer growth. The lab studies how renal cell carcinoma, a common kidney cancer, depends on asparagine for its survival and proliferation. Their work explores ways to target this dependency to improve treatment strategies, including the use of existing FDA-approved drugs like L-asparaginase and metformin.

Dr. Rebecca E Oberley-Deegan's lab focuses on enhancing the safety and efficacy of radiation therapy for rectal cancer. The primary research investigates a novel antioxidant drug, BMX-001, which aims to protect normal tissues from damage while targeting cancer cells. The lab conducts preclinical studies and clinical trials to assess BMX-001's protective effects and identify biomarkers for radiation damage.

Molly Ohainle's lab focuses on understanding how human cells defend against HIV and related viruses from primates. They investigate the molecular mechanisms by which certain host genes can restrict the infection of these viruses. The research aims to identify and manipulate host factors that limit HIV replication, which could lead to new treatments or even a cure for HIV infection.

Dr. Brian Lin's research lab at Tufts University focuses on understanding how our sense of smell declines with age. They have developed a new model that mimics accelerated aging in the olfactory epithelium, which could pave the way for finding treatments for age-related smell disorders like anosmia. The lab aims to explore the mechanisms behind this decline and test potential therapies to restore olfactory function.

Dr. Christine M. Eischen's lab at Thomas Jefferson University focuses on studying oral squamous cell carcinoma (OSCC), a common and aggressive oral cancer. The research aims to uncover new vulnerabilities in OSCC, especially in cases where the tumor suppressor p53 is inactivated, to improve treatment methods. The lab is investigating a novel protein degrader that targets Mdm2, a protein essential for the survival of p53-null cancers, with the goal of increasing tumor immunogenicity and overcoming resistance to current therapies.